AIDSmeds Founder Peter Staley interviewed Dr. Martin Markowitz of the Aaron Diamond AIDS Research Center and one of the investigators who announced very promising results about MK-0518, Merck's new integrase inhibitor, the first in a completely new class of anti-HIV drugs.
Click here to listen to the 5 minute interview. (5.0 MB mp3 file)
If you don't understand one of the words in this article,
just double-click it. A window will open with a definition
from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
